No Data
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $111
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
NeuroOne Expects Higher Fiscal Q1 Revenue -- Shares Up
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $111